Clonidine Tablets of 0.15 Mg; Tender in Ukraine - 143236595

Procurement Summary

Country: Ukraine

Summary: Clonidine Tablets of 0.15 Mg; Captopril/Hydrochlorothiazide, Tablets, 50/25 Mg Each; Barbiturates in Combination (Ethyl Ether of A-Bromosovaleric Acid 18 Mg, Phenobarbital 17 Mg, Menthol Solution in Menthyl...

Deadline: 16 Jun 2026

Posting Date: 13 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 143236595

Document Ref. No.: UA-2026-06-11-010611-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 90000

CPV Classification

33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33660000 - Medicinal products for the nervous system and sensory organs
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Clonidine tablets of 0.15 mg; Captopril/hydrochlorothiazide, tablets, 50/25 mg each; Barbiturates in combination (ethyl ether of a-bromosovaleric acid 18 mg, phenobarbital 17 mg, menthol solution in menthyl ether of isovaleric acid 80 mg) oral drops of 25 ml; Glycine sublingual tablets of 100 mg; Amoxicillin tablets/dispersible tablets of 500 mg; Amoxicillin/clavulanic acid film-coated tablets, 875 mg/125 mg; Ciprofloxacin film-coated tablets, 500 mg each; Azithromycin tablets/capsules of 500 mg; Meloxicam 15 mg tablets; Diclofenac tablets/capsules of 50 mg; Validol tablets of 100 mg; Metamizole sodium, 500 mg tablets; Lisinopril/hydrochlorothiazide 10 mg/12.5 mg tablets; Lisinopril/hydrochlorothiazide tablets of 20 mg/12.5 mg; Carbamazepine 200 mg tablets; Chloramphenicol 500 mg tablets; Cefazolin, powder for injections of 1 g; Omeprazole 20 mg capsules; Ambroxol syrup, 30 mg/5 ml 100 ml bottle; Ambroxol syrup, 15 mg/5 ml 100 ml; pancreatin, Lipolytic units: 8000; Activated charcoal tablets/capsules of 250 mg; Nimesulide, granules (granulated powder) for oral suspension, 100 mg/2 g, 2 g each; Moxonidine tablets of 0.2 mg; Moxonidine tablets of 0.4 mg; Pregabalin, capsules, 300 mg each; Dexamethasone, solution for injection 4mg/ml; Drotaverin tablets 40 mg; Drotaverin tablets 80 mg Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Oral drops, Volume: 25 milliliters, Packaging type: Vial, Ethyl ether of alpha-bromosovaleric acid: 18 mg, Phenobarbital: 17 mg, Solution of menthol in menthyl ether of isovaleric acid (validol): 80 mg; Glycine: N07X, Glycine, Sublingual tablets, 100 mg, Blister; Lisinopril/hydrochlorothiazide 10 mg/12.5 mg tablets; Lisinopril/hydrochlorothiazide tablets 20 mg/12.5 mg; Moxonidine: Classification according to ATC: C02AC05, Classification according ...

Documents

 Tender Notice